Clinical Trials Logo

Nasopharyngeal Sample clinical trials

View clinical trials related to Nasopharyngeal Sample.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04386551 Completed - Sars-CoV2 Clinical Trials

Detection of COVID-19 in Saliva Collection

SALICOV
Start date: May 6, 2020
Phase:
Study type: Observational

Since December 2019, the world has faced a pandemic of COVID-19, an infectious disease caused by SARS-CoV-2, a virus that emerged in China. The reference diagnosis is based on the search for the SARS-COV-2 genome in the nasopharyngeal sample. Carrying out this sample requires the competence of a healthcare professional and presents some inconveniences for the tested patient. Because saliva collection is simple, non-invasive, painless and inexpensive, and can be performed by poorly trained personnel, it could be an alternative to the reference nasopharyngeal sample. SARS-CoV2 detection in human saliva could be a potential diagnosis of COVID infection.